A Phase 2/3 randomized controlled semi-blinded trial to investigate safety and effectiveness in visualization of the ureters with nizaracianine triflutate, administered intravenously in up to three divided doses, in participants (18 years or older) undergoing abdominopelvic surgical procedures [TRIPHASE Trial]
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Digestive Health and Surgery -
Location
-
Principal Investigator
-
Sponsor
Curadel Surgical Innovations
The purpose of this research is to study the safety and effectiveness of an experimental research drug called Nizaracianine triflutate (nizaracianine) (study drug) when it is used to visualize the ureters (tube that connects the kidneys to the urinary bladder) during your scheduled surgery.
Enrollment Form
This study is currently enrolling.